Recent Updates
Recently added Catalysts
RDY

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Stock Exchange of India Ltd. York Stock Exchange Inc. Form 6-K for the quarter ended December 31, 2021, filed with United States Securities and Exchange Commission. is to inform you that the Company has filed its unaudited condensed consolidated interim financial statements pr

Full Press Release Details

Stock Exchange of India Ltd.
York Stock Exchange Inc.
Form 6-K for the quarter ended December 31, 2021, filed with United States Securities and Exchange Commission.
is to inform you that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS
in Form 6-K for the quarter ended December 31, 2021, with the United States Securities and Exchange Commission on January 28,
2022. A copy of the Form 6-K is attached. The Form 6-K is also available on the Company's website, www.drreddys.com.
is for your information.
Dr. Reddy's Laboratories Limited
/s/ Vivek Mittal
Vivek Mittal
Global General Counsel and Compliance officer
CC:- New York Stock Exchange Inc.(Stock Code :RDY)
IFSC Ltd. (Stock Code: DRREDDY)
Last updated: Jan 29, 2022